Phenoxymethylpenicillin represses the final cross-linking stage of peptidoglycan creation through the binding and inactivation of transpeptidases on the inward surface of the bacterial cell layer, therefore hindering bacterial cell wall synthesis. It might be less active against some microorganisms, especially gram-negative microbes. It is used in the treatment of mild to moderate infections.